Y Intercept (Hong Kong) LTD Ironwood Pharmaceuticals Inc Transaction History
Y Intercept (Hong Kong) LTD
- $1.37 Billion
- Q1 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 39,782 shares of IRWD stock, worth $24,267. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,782
Previous 15,147
162.64%
Holding current value
$24,267
Previous $67,000
13.43%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IRWD
# of Institutions
222Shares Held
166MCall Options Held
11.2MPut Options Held
6.9K-
Black Rock Inc. New York, NY22.9MShares$14 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$10 Million6.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.7MShares$9.57 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY13.7MShares$8.36 Million0.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.94MShares$6.06 Million0.02% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $93.5M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...